Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jon S. Mynderse is active.

Publication


Featured researches published by Jon S. Mynderse.


Biochemical Pharmacology | 1991

Studies on the mechanism of action of A80915A, a semi-naphthoquinone natural product, as an inhibitor of gastric (H+-K+)-ATPase

Anne H. Dantzig; Pamela L. Minor; James L. Garrigus; David S. Fukuda; Jon S. Mynderse

A semi-naphthoquinone natural product, A80915A, produced by Streptomyces aculeolatus was found to be a potent inhibitor of gastric (H(+)-K+)-ATPase, the enzyme responsible for acid secretion in the stomach. Enzyme activity was measured by potassium-stimulated hydrolysis of ATP or p-nitrophenolphosphate with enzyme prepared from the stomach fundic mucosa of pigs. Concentration-dependent inhibition was observed with an IC50 of about 2-3 microM for both ATPase and p-nitrophenylphosphatase. A Hill plot indicated that the enzyme has two binding sites for A80915A. Inhibition was not affected by the presence of the reducing agent dithiothreitol, indicating a lack of involvement of enzyme sulfhydryl groups. A 30-min incubation of enzyme with increasing drug concentrations followed by a 10-fold dilution did not alter the IC50, indicating that A80915A does not covalently modify the enzyme. Coincubation of enzyme with 3.8 microM A80915A resulted in time-dependent inhibition. The rate of inhibition was slowed significantly by the presence of 20 mM potassium, rubidium and ammonium but not by 20 mM sodium, lithium and choline, or by 40 mM sucrose. The level of inhibition was influenced by the order of addition of potassium and drug to the enzyme. Taken together, these studies indicate that inhibition by A80915A is dependent on the conformation of gastric (H(+)-K+)-ATPase and that potassium slows the rate of inhibition by converting the enzyme to a conformation where the drug binding site is not as accessible. The mode of action of A80915A is distinct from that of two well characterized proton pump inhibitors, omeprazole and SCH 28080.


Tetrahedron | 1991

A82775b and a82775c, novel metabolites of an unknown fungus of the order sphaeropsidales

Dale R. Sanson; Hanna Gracz; Michael S. Tempesta; David S. Fukuda; Walter Mitsuo Nakatsukasa; Thomas H. Sands; Patrick J. Baker; Jon S. Mynderse

Compounds A82775B (1) and A82775C (2) were isolated as non-antimicrobial by-products during attempts to isolate an elusive G+, G- antibiotic from culture A82775. an unidentified mold. A82775 factors B and C are present in both the mycelium and filtered broth. The metabolites were recovered from the filtered broth by adsorption on Diaion HP-20 nonfunctionalized macroreticular resin and purified by preparative reverse phase HPLC on C18 bonded phase supports. The structure elucidation of A82775 factors B (1) and C (2) has been accomplished by spectroscopic means including COSY, NOESY, INAPT, HMQC and 2D-INADEQUATE NMR experiments.


Tetrahedron Letters | 1993

Structures of A88696 C,D and F: Gastric ATP-ase inhibitors

Rosanne Bonjouklian; Jon S. Mynderse; Ann H. Hunt; Jack B. Deeter

Abstract The structures of A88696C ( 1 ), D ( 2 ) and F ( 3 ), isolated from Streptomyces sclerotialus , are described on the basis of spectroscopic analysis. 1 and 3 are spirotetronic acid-containing macrolides, and 2 is the β-dicarbonyl tautomer with a spiroepoxide at the α-site of the lactone ring.


The Journal of Antibiotics | 1990

A80915, a new antibiotic complex produced by Streptomyces aculeolatus. Discovery, taxonomy, fermentation, isolation, characterization, and antibacterial evaluation.

David S. Fukuda; Jon S. Mynderse; Patrick J. Baker; Donnis M. Berry; Laverne Dwaine Boeck; Raymond C. Yao; Frederick P. Mertz; Walter Mitsuo Nakatsukasa; James A. Mabe; John L. Ott; F. T. Counter; P. W. Ensminger; Norris E. Allen; W. E. Alborn; J N Hobbs


The Journal of Antibiotics | 1990

A54145 a new lipopeptide antibiotic complex: microbiological evaluation.

F. T. Counter; Norris E. Allen; David S. Fukuda; J N Hobbs; John L. Ott; P. W. Ensminger; Jon S. Mynderse; D. A. Preston; C. Y. E. Wu


The Journal of Antibiotics | 1990

A54145, A NEW LIPOPEPTIDE ANTIBIOTIC COMPLEX: DISCOVERY, TAXONOMY, FERMENTATION AND HPLC

Laverne Dwaine Boeck; H. R. Papiska; Roger W. Wetzel; Jon S. Mynderse; David S. Fukuda; Frederick P. Mertz; Donnis M. Berry


The Journal of Antibiotics | 1988

Structure elucidation of A58365A and A58365B, angiotensin converting enzyme inhibitors produced by Streptomyces chromofuscus

Ann H. Hunt; Jon S. Mynderse; Susan K. Samlaska; David S. Fukuda; George M. Maciak; Herbert A. Kirst; John L. Occolowitz; John K. Swartzendruber; Noel D. Jones


The Journal of Antibiotics | 1987

METHOD FOR THE DETECTION AND QUANTITATION OF CHITINASE INHIBITORS IN FERMENTATION BROTHS; ISOLATION AND INSECT LIFE CYCLE EFFECT OF A82516

Penelope J. B. Somers; Raymond C. Yao; Lawrence E. Doolin; Michael J. Mcgowan; David S. Fukuda; Jon S. Mynderse


The Journal of Antibiotics | 1990

A54145, a new lipopeptide antibiotic complex : isolation and characterization

David S. Fukuda; R. H. Du Bus; Patrick J. Baker; Donnis M. Berry; Jon S. Mynderse


The Journal of Antibiotics | 1990

A54145, A NEW LIPOPEPTIDE ANTIBIOTIC COMPLEX: MICROBIAL AND CHEMICAL MODIFICATION

David S. Fukuda; Manuel Debono; R. M. Molloy; Jon S. Mynderse

Collaboration


Dive into the Jon S. Mynderse's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge